Post-study coding: Duration of treatment was divided into time periods of weeks and months.
Data Analysis:
Data was transferred by the primary researcher to an Excel spreadsheet and analysed using Microsoft Excel.
Ethical Considerations:
Ethics approval was sought and received from Mid-Western Regional Ethics Committee in June 2013.
Results
During the 6 month period, 64 cases were referred to the oedema service, involving 61 individuals. 1 patient was excluded, as they had no oedema and were referred preventatively for advice/education. The population referred is reported in Table 1 .The occurrence of lymphoedema (29%), non-lymphatic oedema (16%), mixed oedema (46%) and lymphorrhoea (16%) was reported.
Further details have previously been published . 92% had a cancer diagnosis. 39 (61%) were treated at home, 14 (22%) as inpatients, the remainder as out-patients or in more than one setting. Treatment duration lasted from 1-176 days (median 7).
Assessment and goals:
Patients were assessed using a number of different methods, more than one being used for most patients. The most common method of assessment was circumferential measurements (78%), followed by skin descriptors (73%) and function (72%) using EFAT-2 (Kaasa and Wessel 2001) . See Figure 1 .
The treatment goals are outlined in Figure 2 : for most patients, more than one goal was identified. Goals were a mixture of maintenance and improvement. The most common goals were to maintain skin integrity (54%), to reduce limb volume (51%) and to improve QOL (48%).
Interventions used:
All patients received at least one intervention, most received more than one type. All received education about their oedema. Compression garments (57.7%) and multi-layer bandaging (50%) were the most commonly used physical treatments. Manual lymphatic drainage (MLD) and K-taping were only used on those with a lymphoedema component to their oedema (See Table 2 ). Closed subcutaneous drainage, as described by Clein and Pugachev (2004) , was not used during the study period, despite being an available option by our medical team. Treatment duration ranged from 1-176 days, being shortest for those with a mixed oedema type (See Table 3 ). The average number of treatments was 3.5, and was highest for those with lymphoedema.
The main reasons for ceasing oedema treatment were due to death and clinical deterioration. 19% were discharged because their oedema had stabilised and no longer required professional input.
75% of oedema patients also received other physiotherapy treatments( e.g. mobility, breathlessness, pain interventions) while being treated for oedema.
Discussion:

Assessment and Tools:
The most common assessment tool used was circumferential measurements (78%). They are easy to use, have good reliability (Taylor 2006) and remain the first choice recommendation for lymphoedema practitioners (Perdemo et al 2014; ILF 2006) . Skin descriptors [i.e. description of skin colour, texture and surface by the clinician] were the next most commonly-used measurement (73%). The detrimental effects of oedema on skin quality and function are well described in the literature (Flour 2013; Nowicki and Siviour 2013; ILF 2012) however, to date, there is no standard measurement for the observed effects of oedema on skin. This proves an enormous challenge to research in this field. Photographs, used in 5% of cases, are very useful clinically and in case studies for observing changes in skin appearance and limb volume/shape, but it is difficult to quantify and analyse the information contained therein for research purposes. Functional measures, both EFAT-2 (Kaasa and Wessel, 2001 (72%) and other descriptions of function (43%)[ ability to walk, transfer, level of assistance required] were used to measure impact of oedema on function. The authors suggest that oedema-specific functional tools may be required to fully capture the effect of treatments on function in this patient population, such as the physical domains of lymphoedema QOL tools. QOL tools were rarely used (13%) by the service, mainly due to lack of a suitable tool for palliative care patients. At the time of study, just one QOL tool was available for both leg and arm, the LYMQOL . Our service found it to be suitable for a small proportion of highly functioning patients, but too complicated and burdensome for many. Newer tools, such as Lymph-ICF-LL (Devoogdt et al 2014) are relatively lengthy. The development of a short oedema-specific QOL tool for palliative care patients is imperative for quality research to occur in this patient population.
Aims of Treatment:
Unlike the general oedema population, where volume reduction is most frequently the goal, the most salient difference in our palliative care population was that other treatment effects were commonly the goal, and that maintenance (i.e. preventing deterioration) was often the primary treatment aim. As the International Lymphoedema Framework (ILF 2012) stated, outcomes of comfort and function may be more important in palliative care patients. Maintaining skin function was the most common goal of treatment (53%) and improving skin was the goal for 36%. This indicates the importance of skin issues in this patient population, once again highlighting the lack of a suitable assessment tool for this purpose. Reducing volume was the goal for just half the patients (50%) and maintaining volume was the goal for 34%. This pointedly reflects the pragmatism of treating palliative care patients with oedema/lymphoedema, for whom a decrease in volume may not be realistic or possible.
Improving function was a goal in 36% of patients. Clinically, it is observed that walking and bed transfers become more difficult when lower limbs are swollen, and that feeding and personal care become difficult with upper limb oedema. Improving these functional tasks is therefore a reasonable goal of treatment. Improving QOL was the goal in almost half the patients (47%). QOL in palliative care patients is linked with physical and social functioning, subjective appraisal of symptoms and wellbeing (Kaasa and Loge 2003) . Most of the oedema literature alludes to the emotional effect of having oedema, but only one paper was found specifically dealing with the subject (Creedon 2011) : Oedema results in disfigurement causing distress, body image and relationship issues; clothing becomes difficult to buy and wear; functional tasks become more difficult which may lead to reduced activity and participation; and there is also a sense of loss of control. In addition, in advanced disease lymphoedema also made patients fearful of the future (Frid et al 2006) , as it depicted change and possible decline. Anecdotally, palliative care patients report better wellbeing and functioning after oedema treatments but there is no research to date, which examines these findings in greater detail. Reduction in pain was an aim for 14% (n=9) of patients. Pain due to oedema/lymphoedema itself is not well described in the literature, although one non-palliative cohort of lymphoedema patients reported an incidence of 60% when specifically asked (Ryan et al 2003) . Patients may describe altered sensations, such as heaviness, tightness or tenderness (Frid et al 2006 , Ryan et al 2003 . Clemens et al (2010) showed a clinical reduction in oedema-related pain in palliative care patients after manual lymphatic massage. It is possible that the pain-reducing effect of treatment is underestimated by clinicians, and therefore infrequently measured. Improving balance was cited as an aim in 13% (n=8) of patients. Although this is not reported in the literature, clinicians have found that unilateral swelling or ascites can significantly alter a patient's base of support and affect both static and dynamic balance. In our service, treatments have been found to mitigate this.
Interventions used:
All patients treated received education as part of their treatment [causes of swelling, skincare management, precautions, footwear advice, self-management techniques]. This compares with 95% for a similar PC service (Thompson and Walker 2011) . Education is seen as an intrinsic part of oedema care (ILF & CLF 2010, Todd 2013b), encouraging self-management of the condition. External compression [compression garments (59%), bandaging (51%)] was the most commonly used physical treatment for all oedema types. Bandaging reduces limb volume and improves limb -shape, however long-term management is achieved through compression garments (Cooper2015, Cooper 2013). Bandaging is known to reduce or stop fluid leakage from the skin (Jones 2011; Delon 2012) , therefore all of our patients with lymphorrhoea were bandaged. Only those with a lymphatic component received lymphatic massage and kinesiotaping. Lymphatic massage involves strategic massage of lymph nodes to improve their functioning, complemented with superficial massage along skin, which directs lymphatic fluid to the nearest functioning deep lymphatics. It is not used for non-lymphatic oedema (Todd 2013) . Some authors have suggested that part of its therapeutic value may be through the power of touch on ill and frail patients (Towers et al 2010; ILF &CLF 2010) . Kinesiotaping taping was also only used for patients with lymphoedema. K-tape is elasticated tape, applied strategically to areas where superficial lymphatic flow is affected. When the patient moves the affected area, the tape stretches in a multidirectional fashion. This is believed to stimulate the superficial lymphatics. It can only be used on good quality skin and is considered to be of use in areas of localised swelling (Thompson and Walker 2011) . There is much anecdotal evidence for its use, but research is lacking (Wigg and Lee 2013) . Exercise and deep breathing were used as interventions in 38% and 34% of patients respectively. Both are seen as adjuncts to oedema management by assisting lymphatic flow and increasing the efficiency of anatomical pumps (ILF & CLF 2010) but their effectiveness has yet to be estabished.
Treatment duration and number of treatments:
Treatment duration (see Table 3 ) shows that interventions for oedema are typically of short duration: 28% were seen for 1 visit only and 52% were seen for less than 1 week. There was, however, a cohort of patients who received numerous treatments over a prolonged length of time, indicating that some palliative care patients have longer-term oedema issues, which may respond to physical treatments. Regarding discharge from the service, the most common reasons were due to death (37%) or clinical deterioration (21%). This highlights the unstable population of patients being treated for oedema, many nearing end of life. Conversely, 19% of patients were stable and discharged because their oedema was controlled and being self-managed. The authors suggest that at least 3 possible cohorts of patients are being seen by the service: 1) those for whom a short episode of advice is required, followed by self-maintenance; 2) those for whom oedema is a harbinger for terminal decline -these require supportive measures and treatment is of short duration; 3) those for whom a longer period of treatment is required, followed by a maintenance period or decline. This latter cohort may be most likely to show the benefits of oedema interventions and needs to be investigated. Three in every 4 patients also received other physiotherapy interventions, once referred to the oedema service. This suggests that an oedema service fits in well as part of a palliative care physiotherapy service, as other physical needs can be assessed at the time of referral. In addition, most of the patients were treated at home or as outpatients: oedema often occurs when the patient is free of other major symptoms, and in our service only infrequently requires an inpatient admission for treatment.
Conclusion
Oedema treatments for palliative care patients are adapted from traditional CDT methods used for treating lymphoedema and oedema in the general population. This study assessed the treatment goals, assessment methods and treatments used for a cohort of palliative care patients with oedema. Different interventions were used for different oedema types. Education (100%), compression garments (59%) and bandaging (51%) were the most commonly used interventions. The goals of treatment focussed on maintaining or improving skin quality, function and QOL rather than merely the reduction of limb volume. Treatment was typically of short duration, but there was a cohort of patients who required prolonged oedema treatment. The assessment of oedema for research purposes is hampered by lack of tools to measure skin quality and oedema-related QOL in palliative care patients. Research is required to measure the effectiveness of CDT in palliative care patients and to identify patient cohorts who benefit from this treatment approach.
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